| Application no. and date | 08827826.2 (espacenet) (Federated) (European Patent Register), 20080702 | | Patent/reg. no. and date | DK/EP 2173349, 20110309 | | Publication date | 20100414 | | Priority no. and date | FR 0704868, 20070705 | | EP pub. no. and date |
EP 2173349 20100414 | | Effective date | | | Applicant/owner | Aventis Pharma S.A., 20, avenue Raymond Aron
92160 Antony, FR | | Applicant ref. no. | AVENT FR2007/053 | | Inventor | BISSERY, Marie-Christine, c/o Sanofi-Aventis
Département Brevets
174 Avenue de France
F-75013 Paris, FR,
VRIGNAUD, Patricia, c/o Sanofi-Aventis
Département Brevets
174 Avenue de France
F-75013 Paris, FR,
CHIRON-BLONDEL, Marielle, c/o Sanofi-Aventis
Département Brevets
174 avenue de France
F-75013 Paris, FR,
LEJEUNE, Pascale, c/o Sanofi-Aventis
Département Brevets
174 avenue de France
F-75013 Paris, FR | | Representative | | | Opponent | | | IPC Class | A61K 31/4745 (2006.01) , A61K 38/16 (2006.01) , A61P 35/00 (2006.01) | | Title | Antitumor-kombinationer med et VEGF-hæmmende middel og irinotecan | | Int. application no. | FR2008000943 | | Int. publication no. | WO2009024667 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
